Shares of medical device company DexCom (NASDAQ:DXCM) jumped 2.6% in the morning session after the company announced it would present new product features and positive clinical data at the European ...

DexCom announced that Chairman and CEO Kevin R. Sayer has taken a temporary medical leave as of September 14, 2025, with President and COO Jacob S. Leach appointed interim CEO and Mark Foletta as ...

The retail tie-up, RxSmartSaver, could help customers access GoodRx savings services for branded treatments at nearly 2,200 ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $99.3, a high estimate of $106.00, and a low estimate of $89.00. Marking an ...

Now, it’s worth noting Stock Advisor's total average return is 1,079% — a market-crushing outperformance compared to 191% for the S&P 500. Don’t miss out on the latest top 10 list, available when you ...

The device, called Biolinq Shine, is indicated for people with Type 2 diabetes who don’t depend on insulin.

(NASDAQ: DXCM), the global leader in glucose biosensing, announced today the launch of its first open call in the U.S. and Canada in search of the next diabetes advocates. Those selected will ...

Global equities are likely to continue edging higher even as valuation concerns continue to arouse fear among investors.

Shares of DexCom Inc. tumbled 10.99% to $67.45 Friday, on what proved to be an all-around great trading session for the stock ...

The report claims that inaccurate readings from the G7 device have resulted in hospitalizations and deaths among diabetic patients. According to Hunterbrook, an FDA inspection revealed DexCom made an ...

Health Panels follows the lead of competitors by offering blood tests that users can schedule and review within the Oura app.

Stuart Lancaster's reign as Connacht head coach begins with a 26-15 win over Benetton in the United Rugby Championship at the Dexcom Stadium.